• Genticel, of Toulouse, France, appointed Didier Hoch to its board.

• GenVec Inc., of Gaithersburg, Md., elected Adel A. F. Mahmoud and Edward M. Connor Jr. to its board.

• Immunovaccine Inc., of Halifax, Nova Scotia, added Brad Thompson to its board.

• InDex Pharmaceuticals AB, of Stockholm, Sweden, appointed Jesper Wiklund CEO, effective Sept. 1.

• Inovio Pharmaceuticals Inc., of Blue Bell, Pa., named Aytar Dhillon nonexecutive chairman.

• Insmed Inc., of Monmouth Junction, N.J., named Andrea (Andi) Holtzman Drucker senior vice president, general counsel and corporate secretary.

• Intellikine Inc., of La Jolla, Calif., named Gregory I. Berk chief medical officer.

• Intrexon Corp., of Blacksburg, Va., appointed Glenn E. Nedwin president of its human therapeutics division and a senior vice president of the firm. It also named Timothy D. Kasbe senior vice president and chief information officer.

• InVivo Therapeutics Inc., of Cambridge, Mass., named Jonathan R. Slotkin medical director.

• Marina Biotech Inc., of Bothell, Wash., named R. John Fletcher to its board and appointed James Karis chairman.

• Medicure Inc., of Winnipeg, Manitoba, appointed Dawson Reimer president and chief operating officer.

• Medivation Inc., of San Francisco, promoted Stewart Hallett to vice president of clinical operations.

• NeoStem Inc., of New York, added Joe Talamo as vice president, corporate controller and chief accounting officer.

• NeurOp Corp., of Atlanta, elected Robert R. Bonczek to its board.

• Nuvo Research Inc., of Mississauga, Ontario, appointed Eric Vandal vice president of sales and marketing and named Arnold Gammaitoni vice president of scientific affairs in is pain group.

• Olink AB, of Uppsala, Sweden, promoted Simon Fredriksson to executive vice president.

• Omthera Pharmaceuticals Inc., of Bedminster, N.J., appointed Ben Machielse executive vice president and chief operating officer.

• Oncolytics Biotech Inc., of Calgary, Alberta, appointed George M. Gill chief medical officer.

• OncoSec Medical Inc., of San Diego, appointed Anthony E. Maida III to its board.

• Oramed Pharmaceuticals Inc., of Jerusalem, appointed Michael Berelowitz chairman of the scientific advisory board.